Jason Chiang, MD, PhD & Clayton Wiley, MD, PhD University of Pittsburgh Medical Center Department of Pathology Division of Neuropathology.

Slides:



Advertisements
Similar presentations
Case Study 5 Gabrielle Yeaney, M.D.. Question 1 63-year-old female with progressive weakness of upper and lower extremities, in additiona to confusion,
Advertisements

Devic’s neuromyelitis optica: its distinctive features and treatment
Overview of Multiple Sclerosis  Valerie Robinson, D.O. 
IgG IEF Diagnosing Multiple Sclerosis. Multiple Sclerosis CNS disorder Scar formation on outside of nerve cells of brain and spinal cord Inflammation.
Rituximab (RITUXAN) & Multiple Sclerosis
Progressive Multifocal Leukoencephalopathy July 31, 2007 Margo Smith, M.D. Department of Medicine Washington Hospital Center.
Diagnostic Slide Session Case Sandra Camelo-Piragua 1, Ronald A Goerss 2 and David N Louis 1 1 Pathology Department, Massachusetts General Hospital,
A 52-year old man with recently diagnosed HIV infection with irregular shaking of his hand Teaching NeuroImages Neurology Resident and Fellow Section ©
Multiple Sclerosis Abdulelah Nuqali Intern. DemyelinationCNSAquired Multiple Sclerosis Optic neuritis Acute Disseminated Encephalomyelitis Hereditary.
Cahalans-Month-of-Madness/
Multiple sclerosis Pathology. Key principles Myelin function The differences between CNS and PNS Myelin Primary Demyelinating disease classification Multiple.
Neuropathology Lab I MHD II
HIV dementia and HIV-related brain impairment (HRBI) Jeanette Meadway FRCP Consultant Physician Mildmay Hospital UK Hackney Road, London E2 7NA.
“I Think My 17 Month Old Baby’s Drunk” Daniel P. Davis, MD UCSD Emergency Medicine.
National Prion Disease Pathology Surveillance Center University Hospitals Case Medical Center Pedro Ciarlini MD Yezid Gutierrez MD PhD Pierluigi Gambetti.
Multiple sclerosis (MS) – is a chronic disease that begins most commonly in young adults and is characterized pathologically by multiple areas of central.
An Analysis of Monthly Surveillance 3T MRI in MS patients switched from long term natalizumab to teriflunomide in a controlled, prospective study K. Edwards,
Dallas, TX November 2–4, 2012 Multiple Sclerosis Shirley O’Leary MS NP-C MSCN Texas Neurology Dallas, Texas Mary L. Filipi APRN, PhD Neurology Associates,
Clinical Correlations The NYU Internal Medicine Blog A Daily Dose of Medicine
MedPix Medical Image Database COW - Case of the Week Case Contributor: Steven J Goldstein Affiliation: University of Kentucky.
Multiple Sclerosis Rohith M. Reddy. Multiple sclerosis (MS) involves an immune-mediated process in which an abnormal response of the body’s immune system.
Boston Medical Center is the primary teaching affiliate of the Boston University School of Medicine. PRESENTATION TITLE Subtitle & Date.
1 Copyright © 2014 Elsevier Inc. All rights reserved. Chapter 43 Nervous System Complications of Systemic Viral Infections John E. Greenlee.
Prepared by the AETC National Resource Center based on recommendations from the CDC, National Institutes of Health, and HIV Medicine Association/Infectious.
Sagittal FLAIR images - Stable nonenhancing hyperintensities within the pericallosal white matter and bilateral centrum semiovale, consistent with known.
Multiple Sclerosis A chronic, progressive central nervous system disease with a disseminating demyelination of the nerve fibers of the brain and spinal.
Adult Medical-Surgical Nursing Neurology Module: Multiple Sclerosis.
Practical Management of MS in the Primary Care Office Setting Case Study 1.
Int J MS Care 7: , 2005/2006. Jan 9 & 10, Clinical Stabilization of a MS Patient after Tonsillectomy presented by Michael C. Levin, MD Department.
MS مولتیپل اسکلروزیس. Client with Multiple Sclerosis Description Chronic demyelinating disease of CNS associated with - abnormal immune response to environmental.
2011 AANP Diagnostic Slide Session Case 1 Janna Neltner, MD Dianne Wilson, MD Peter T. Nelson, MD PhD Craig Horbinski, MD PhD University of Kentucky.
Tysabri ® (natalizumab) Biogen Idec Inc. BLA /15 Peripheral and Central Nervous System Drugs Advisory Committee Gaithersburg, Maryland March 7-8,
Lananh Nguyen, M.D. Division of Neuropathology University of Pittsburgh Medical Center 24 year old male found unconscious.
Teaching NeuroImages Neurology Resident and Fellow Section © 2013 American Academy of Neurology Cerebral White Matter Involvement in a Patient with Bilateral.
* Creutzfeldt–Jakob disease Posterior Reversible Encephalopathy Syndrome Progressive Multifocal Leukoencephalopathy.
MRI showing plaque of multiple sclerosis.
PRIMARY DISEASES OF MYELIN. Acquired forms - Characterized by preferential damage to previously normal myelin with relative preservation of axons and.
Clayton Wiley MD/PhD. 38-year-old male with progressive weakness of upper and lower extremities, in addition to confusion. Describe the MRI findings (location,
STUDY ON THE LEVELS OF TAU AND β-AMYLOID IN CSF OF PATIENTS WITH MULTIPLE SCLEROSIS Levente Szalárdy MD Department of Neurology University of Szeged Hungary.
Date of download: 6/6/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Lessons Learned From Fatal Progressive Multifocal.
Prepared by the AETC National Coordinating Resource Center based on recommendations from the CDC, National Institutes of Health, and HIV Medicine Association/Infectious.
Cerebrospinal fluid. The subarachnoid space on the outside of the brain is in continuity with a similar space around the spinal cord and also with the.
Multiple sclerosis – late onset. Authors: Vitalie Vacaras Vitalie Vacaras Damian Popescu Damian Popescu Radu Antonescu Radu Antonescu Anca Simu Anca Simu.
POSTER TITLE: CLINICAL AND RADIOLOGICAL PROFILE, TREATMENT AND OUTCOME OF PEDIATRIC ACQUIRED DEMYELINATING DISORDERS OF CENTRAL NERVOUS SYSTEM PRESENTER.
Carrie M. Hersh, D.O., Robert Fox, M.D.
Copyright © 2009 American Medical Association. All rights reserved.
Tumefactive rebound of Multiple Sclerosis following cessation of Fingolimod   Sharfaraz Salam, Daniel Dunbar, Tim Lavin, Adrian Pace, Tatiana Mihalova.
Multiple Sclerosis.
Compared with multiple sclerosis (MS), progressive multifocal leukoencephalopathy (PML) is more likely to produce large, confluent lesions on T2-weighted.
Figure 1 An example of individual prediction of response to interferon β-1a and natalizumab in moderately advanced, active multiple sclerosis. Six treatment.
Case Study 16 Gabrielle Yeaney, M.D..
65 year-old female with Alzheimer’s disease
Clayton Wiley MD/PhD.
Case Study 39 Henry Armah, M.D., M.Phil..
Nat. Rev. Neurol. doi: /nrneurol
Stephen L. Hauser, Jorge R. Oksenberg  Neuron 
Cerebrospinal fluid.
Progressive Multifocal Leukoencephalopathy
Harika Yalamanchili PGY-3
Diagnosing Multiple Sclerosis
Case Study 35 Henry Armah, M.D., M.Phil..
Figure 2 7T MRI can differentiate between early PML and MS lesions Two different patterns of brain lesions were observed using 7T MRI: ring-enhancing lesions.
A 47-year old HIV infected man with jerking of his right hand
Figure 3. Brain imaging and neuropathologic studies in patient PT-5 diagnosed with progressive multifocal leukoencephalopathy Brain imaging and neuropathologic.
Figure 1 Detailed overview of treatment course and paraclinical findings Maximum intensity projection maps of supratentorial inversion recovery images.
Figure 1 MRIs (case 1)‏ MRIs (case 1) An enlarging T2 lesion in the cerebral white matter near the angular gyrus and a new lesion in the left middle cerebellar.
Figure 2 Characteristic MRI features of adult leukodystrophies
Figure A 57-year-old man with relapsing-remitting MS (RRMS) and new-onset ataxia A 57-year-old man with relapsing-remitting MS (RRMS) and new-onset ataxia.
Figure 15a. PMLprogressive multifocal leukoencephalopathy in a 65-year-old woman with multiple medical problems, no known immunosuppressive disease, and.
Figure 4 Longitudinal analysis of peripheral immune cell composition Frequency of naive, central memory (Tcm), and effector memory (Tem) CD4 T cells over.
Presentation transcript:

Jason Chiang, MD, PhD & Clayton Wiley, MD, PhD University of Pittsburgh Medical Center Department of Pathology Division of Neuropathology

67 years old male with multiple sclerosis (MS) for 39 years Treated with Tysabri (Natalizumab) during the past 5 years What is MS? What is Tysabri? Case History 2

New onset of arm dysmetria, slurred speech and choking Describe MRI findings Case History 3

Radiologic Findings - MRI T1 + Contrast RR 4

Radiologic Findings - MRI FLAIR/T2 RR 5

CSF analysis: –Normal differential count and glucose level –Elevated protein level, elevated IgG index and oligoclonal bands Tysabri discontinued, plasmapheresis, IV dexamethasone Why are they stopping the Tysabri? Died 25 days after MRI Further Studies and Clinical Course 6

Gross Neuropathology Findings R R 7

8 Peri-ventricular AreaCerebellum 2x 20x Microscopic Findings H&E

Microscopic Findings LFB/CV Peri-ventricular AreaCerebellum 2x 20x 9

Neurofilament stain 10 Peri-ventricular AreaCerebellum 20x

Further Studies Peri-ventricular Area CD68 CD3 Cerebellum 10x 11 CD8 CD4CD68 CD3

JC Virus in situ Hybridization 12 4x40x Cerebellum

Timeline 13 Death 10/5/2012 MRI 6/5/2012 MRI 9/10/2012 PML Symptoms Tysabri Plasmaphereses Steroid IRIS MS 39 years

Progressive multifocal leukoencephalopathy (PML) –Bilateral cerebellar white matter –Dentate nuclei –Middle cerebellar peduncles Superimposed immune reconstitution inflammatory syndrome (IRIS) Quiescent multiple sclerosis (MS) plaques –Multiple areas of cerebral peri-ventricular white matter –Gray and white matter of spinal cord Final Diagnosis 14